ICH GCP Goes Risk-based

ICH GCP Goes Risk-based

By | 2017-06-14T09:32:41+01:00 June 14, 2017|Comments Off on ICH GCP Goes Risk-based

About the Author:

Professional in the integration of data-driven Risk-based Monitoring (RbM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, PharmaForum, PharmaDay, DGGF, etc. 10+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RbM research to new frontiers for CROs, pharma and biotech companies.

Register Today!

Get Free Test Access